BDBM50010073 3-(2-{3-[(E)-Phenylcarbamoylmethylimino-amino]-7-oxa-bicyclo[2.2.1]hept-2-ylmethyl}-phenyl)-propionic acid::3-[2-(5-oxabicyclo[2.2.1],3-formaldehyde (anilinocarbonyl)hydrazonehept-2-ylmethyl)phenyl]propanoic acid::CHEMBL95872
SMILES: OC(=O)CCc1ccccc1CC1C2CCC(O2)C1C=NNC(=O)Nc1ccccc1
InChI Key: InChIKey=OURMJLFLCWODMX-UHFFFAOYSA-N
Data: 1 Kd
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prostanoid TP receptor (Homo sapiens (Human)) | BDBM50010073 (3-(2-{3-[(E)-Phenylcarbamoylmethylimino-amino]-7-o...) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Pharmaceutical Research Institute Curated by ChEMBL | Assay Description The compound was tested for inhibition of specific binding of [3H]-SQ 29,548 to thromboxane A2 receptor in human platelet membranes | J Med Chem 34: 2882-91 (1991) BindingDB Entry DOI: 10.7270/Q2CJ8CFZ | |||||||||||
More data for this Ligand-Target Pair |